AJMC Staff

What we're reading, January 13, 2017: more states consider contraception laws with Affordable Care Act (ACA) in peril; GOP will speed up timeline to replace ACA; Tom Price will sell his stocks to avoid conflicts.

What we're reading, January 12, 2017: Republicans begin process of repealing Obamacare by passing budget resolution; AbbVie's CEO promises to keep drug price increases to once a year and less than 10%; Cardinal Health will pay $44 million for not reporting suspicious opioid orders.

What we're reading, January 11, 2017: in the last 2 decades, the drug pipeline hasn't gotten any faster; smoking and its side effects cost world economies $1 trillion; and Maryland introduces 2 bills aimed at curbing drug prices.

What we're reading: the Obama administration promises swift action on North Carolina's Medicaid expansion plan; FDA approves long-acting opioid; and a look at where President Barack Obama and President-elect Donald J. Trump stand on 5 areas of health policy and science.

What we're reading, January 9, 2017: how Meals on Wheels is becoming the "eyes and ears" of the healthcare system; unease brewing among Republicans about repealing Obamacare without a replacement; and a doctor at the Cleveland Clinic faces disciplinary actions after publishing anti-vaccine rhetoric.

As the prevalence of chronic obstructive pulmonary disease increases, self-management will become increasingly important. However, a new study has highlighted the difficulties of embedding self-management into routine care.

What we're reading, January 6, 2017: some Democrats are appealing to the GOP to consider bipartisan efforts to overhaul Obamacare instead of repealing it; enrollment for Affordable Care Act plans is up 2.3% over last year; and Democrats demand an ethics probe into Tom Price's stock trades.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

What we’re reading, January 5, 2017: Vice President Joe Biden will create a nonprofit organization to focus on cancer research and drug prices; school telemedicine could help kids stay in the classroom and out of the doctor’s office; bundled payments for joint replacements saved $5577 in spending per episode.

Researchers in Australia conducted a systematic analysis of several randomized control trials that evaluated weight loss as an intervention for breast, endometrial, and ovarian cancer.

What we're reading, January 4, 2017: Republicans in Congress may also make changes to Medicare; churches and faith-based organizations launch syringe exchanges; and judge rules Amgen's PCSK9 patent is valid.

The first patient has been treated with ruxolitinib (Jakafi), by Incyte Corporation, for steroid-refractory acute graft-versus-host disease, as part of the REACH-1 phase 2 trial. The trial is evaluating ruxolitinib in combination with corticosteroids.

What we're reading, January 3, 2017: Colorado's Affordable Care Act exchange misused more than $9 million in federal funds; an over-the-counter birth control may be coming to the United States; and returning health data to patients could reduce health record breaches.

What we're reading, January 2, 2017: drug makers are taking a cautious approach to off-label promotion; Republicans eye changes to Medicaid under Trump administration; and the impact of geography on health.

A review of our peer-reviewed research in the healthcare and mainstream press.

What we're reading, December 30, 2016: fake news has also been prevalent in science in 2016; the CDC is considering lowering the lead level threshold for children; and globalization is tied to rising obesity levels.

What we're reading, December 29, 2016: President-elect Donald J. Trump considers privatizing veterans' medical care; a new task force to improve sharing of pregnancy status data; and medical marijuana legalization reduced traffic fatalities.

What we're reading, December 28, 2016: a county in West Virginia is suing 3 national drug distributors for allegedly fueling the opioid epidemic; CDC awards new funding as another Zika case is reported in Texas; and first drug to treat spinal muscular atrophy approved.

What we’re reading, December 27, 2016: nurses are viewed as most ethical and honest profession in America, followed by pharmacists and physicians; over half of Brazilian women reported avoiding pregnancy due to the Zika virus; cooking interventions may help low-income parents feel more positive about preparing and eating vegetables.

What we're reading, December 26, 2016: Medicare starts looking into drug-resistant infections in hospitals; Republicans may not repeal all of Obamacare's taxes when they repeal the law; and a program that partners drug addicts with police officers to get help.

What we’re reading, December 23, 2016: HHS secretary nominee Rep. Tom Price traded $300,000 in healthcare stocks while sponsoring health-related legislature; an economist and a physician suggest creation of digital health biographies; CMS hopes to incentivize cardiac rehabilitation program participation.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

What we're reading, December 22, 2016: Americans continue to sign up for Obamacare coverage despite Republicans' promise to repeal the law; California is implementing a $3 billion effort to help the state’s neediest individuals; and Zika vaccine shows success.

The expanded use for Novo Nordisk's new basal insulin comes 15 months after the initial FDA approval.

What we're reading, December 21, 2016: researchers are racing to download Obamacare data before Donald Trump takes office; tens of millions of Americans import prescriptions illegally; and 4 more criminal charges in Flint water crisis.

What we’re reading, December 20, 2016: Purdue Pharma, which makes OxyContin, plans to expand its sales of the drug in foreign markets; family members blame hospital for not warning them about low-quality nursing home; a project to place blast sensors on soldiers to learn more about concussions has been discontinued.

The FDA has provided accelerated approval for rupacarib along with the first next-generation sequencing—based companion diagnostic test, for the treatment of women with advanced ovarian cancer.

What we're reading, December 19, 2016: how hospitals are altering routines to address rising drug costs; in Colorado, proponents of the aid-in-dying law are searching for more affordable options for the drug to induce death in terminally ill patients; and the 3000 areas in the United States with higher blood lead levels than Flint, Michigan.

A review of our peer-reviewed research in the healthcare and mainstream press.

What we’re reading, December 16, 2016: consumers now have until December 19 to enroll in a marketplace plan for coverage starting on January 1; 20 states file lawsuit against 6 pharmaceutical companies alleging generic price fixing; women who were tested for the BRCA mutation gene after Angelina Jolie’s announcement may not have been at high risk to begin with.